Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., recently announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Gastrointestinal (GI) Panel, with plans to seek both CE IVD marking and FDA clearance.
The comprehensive 23-target panel tests for common bacteria, viruses and protozoa that cause infectious diarrhea. The test is performed in about an hour directly from stool in transport media.
Hey, check out all the research scientist jobs. Post your resume today!
SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., recently announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Gastrointestinal (GI) Panel, with plans to seek both CE IVD marking and FDA clearance.
The comprehensive 23-target panel tests for common bacteria, viruses and protozoa that cause infectious diarrhea. The test is performed in about an hour directly from stool in transport media.
Hey, check out all the research scientist jobs. Post your resume today!
